2023年5月9日

分享这篇文章提供的新闻Cerus MABA最早的投资之一。我们很高兴在其最终的成功扮演了一个角色。”——Yaniv Sneor纽约,纽约,美国5月9日,2023年中期/ EINPresswire.com——大西洋生物天使(MABA),位于生命科学天使投资人集团今天宣布,其投资组合公司之一,Cerus血管内,由Stryker在大型收购交易。Cerus血管内,英国,私营商业阶段医疗设备公司专注于neurointerventional设备的设计和开发治疗颅内动脉瘤,将加入的Stryker组合,世界领先的医疗技术公司之一。MABA在Cerus血管内的投资(Cerus)强调其承诺支持公司认为将大大提升标准的保健和生命科学产业的产品。Cerus的产品都极大地提高了患者的生活和结果,和共同目标的Stryker Cerus将继续关注积极的病人结果intrasaccular动脉瘤治疗全球允许医生对更大范围的动脉瘤。MABA创始人Yaniv Sneor说道,“Cerus是我们最早的投资之一,和我们的成员都深陷在其最终的成功起到了作用。我们激动Cerus他们杰出的成绩,许多患者成功治疗并保持身体健康签到后经过一段时间的数年。“MABA实体聚合在Cerus最大投资者的块,直接资助其成员以及MABA内部投资基金池二世和外部联合投资基金对非成员国的双轮马车基金即MABA Cerus的参与和支持,包括董事会成员积极参与岗位提供领导和指导,取得了强劲业绩的早期和后期投资者,进而职位MABA领先,成为天使集团两个投资者寻求生命科学和生物技术公司寻求天使投资的机会。Sneor补充道,“MABA很高兴支持Cerus及其管理团队从我们最初的和健壮的尽职调查期间到最近的最后的监管障碍在美国和欧洲,并在Stryker收购Cerus和一个非常可观的投资回报我们的会员和投资者。 In only three years, we have an exciting exit for our members, individually, and for those who invested in 2020, through our internal Pools and our Sidecar Fund I, all of whom will continue to receive distributions as milestones are met over the next several years.” Cerus Endovascular's CE Marked products, the Contour Neurovascular System and the Neqstent Coil Assisted Flow Diverter, will join Stryker's portfolio of aneurysm treatment solutions. The sale positions these products and patients to benefit from Stryker’s global reach and infrastructure, and strengthens and expands Stryker’s hemorrhagic portfolio. About Mid Atlantic Bio Angels Mid Atlantic Bio Angels group (bioangels.net) is an angel investor group focused exclusively on new and emerging life science companies, investing in therapeutics, devices, diagnostics, and digital health companies, with no geographic limitations. Membership in MABA is by invitation only and is extended to active, accredited investors, as well as institutional investors and pharma and device companies wishing to invest alongside the angels. MABA’s members include practicing physicians, executives within small and large life science companies, and corporate members from the industry. MABA also manages Sidecar Fund II, a co-investment fund providing access to MABA’s curated deal flow, for non-MABA members. About Cerus Endovascular Ltd. Cerus Endovascular is a privately owned medical device company based in Fremont, California and Oxford, United Kingdom. They design, develop, manufacture and supply Neurovascular products used by Interventional Neuroradiologists for the treatment of hemorrhagic strokes. About Stryker Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com . Kimberly Macleod